Corcept Therapeutics, Inc. (CORT)
34.24
-5.58
(-14.01%)
USD |
NASDAQ |
Feb 19, 16:00
33.72
-0.52
(-1.52%)
Pre-Market: 08:04
Corcept Therapeutics Research and Development Expense (Quarterly) : 68.85M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 40.04M |
| United Therapeutics Corp. | 127.50M |
| Harrow, Inc. | 3.323M |
| Ultragenyx Pharmaceutical, Inc. | 194.22M |
| Amneal Pharmaceuticals, Inc. | 63.35M |